DOI: 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde


Hagenbeck C, Melcher CA, Janni JW et al.
DETECT III: a multicenter, randomized, phase III study to compare standard therapy alone versus standard therapy plus lapatinib in patients (pts) with initially HER2-negative metastatic breast cancer but with HER2-positive circulating tumor cells (CTC).

J Clin Oncol 2012;
30 (Suppl.) Abstr. TPS1146

Download Bibliographical Data

Search in: